Product
Peginterferon alpha-2a , Ribavirin and Betaine
1 clinical trial
1 indication
Indication
Hepatitis CClinical trial
Comparison of Standard Therapy,Peginterferon Alpha-2a + Ribavirin for 48 Weeks VS Peginterferon Alph-2a + Ribavirin + Betaine for 12 Weeks Followed by 36 Weeks Standard Therapy in Untreated Adults With Chronic Hepatitis C Genotype 1Status: Withdrawn, Estimated PCD: 2010-03-04